Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 418508, 11 pages
http://dx.doi.org/10.1155/2013/418508
Research Article

The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF)

1Departmento de Biologia Celular, Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, FMRP/USP, 14049-900 Ribeirão Preto, SP, Brazil
2Apis Flora Industrial e Comercial Ltda, Rua Triunfo, 945, 14020-670 Ribeirão Preto, SP, Brazil
3Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Avenida do Café s/n., 14049-900 Ribeirão Preto, SP, Brazil
4Laboratório Nacional de Ciência e Tecnologia do Bioetanol—CTBE, Caixa Postal 6170, 13083-970 Campinas, SP, Brazil

Received 11 January 2013; Accepted 18 February 2013

Academic Editor: Wojciech Krol

Copyright © 2013 Juliana I. Hori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Burdock, “Review of the biological properties and toxicity of bee propolis (propolis),” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Banskota, Y. Tezuka, and S. Kadota, “Recent progress in pharmacological research of propolis,” Phytotherapy Research, vol. 15, no. 7, pp. 561–571, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Sforcin, A. Fernandes Jr., C. A. M. Lopes, V. Bankova, and S. R. C. Funari, “Seasonal effect on Brazilian propolis antibacterial activity,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 243–249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. P. de Barros, J. P. B. Sousa, J. K. Bastos, and S. F. de Andrade, “Effect of Brazilian green propolis on experimental gastric ulcers in rats,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 567–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. P. D. Barros, M. Lemos, E. L. Maistro et al., “Evaluation of antiulcer activity of the main phenolic acids found in Brazilian green propolis,” Journal of Ethnopharmacology, vol. 120, no. 3, pp. 372–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Paulino, S. R. L. Abreu, Y. Uto et al., “Anti-inflammatory effects of a bioavailable compound, artepillin C, in Brazilian propolis,” European Journal of Pharmacology, vol. 587, no. 1–3, pp. 296–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. C. Tavares, G. R. M. Barcelos, L. F. Silva, C. C. C. Tonin, and J. K. Bastos, “Propolis-induced genotoxicity and antigenotoxicity in Chinese hamster ovary cells,” Toxicology In Vitro, vol. 20, no. 7, pp. 1154–1158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Murad, S. A. Calvi, A. M. V. C. Soares, V. Bankova, and J. M. Sforcin, “Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis,” Journal of Ethnopharmacology, vol. 79, no. 3, pp. 331–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Berretta, A. P. Nascimento, P. C. Bueno, M. M. Vaz, and J. M. Marchetti, “Propolis standardized extract (EPP-AF(R)), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds,” International Journal of Biological Sciences, vol. 8, no. 4, pp. 512–521, 2012. View at Publisher · View at Google Scholar
  10. P. A. de Castro, M. Savoldi, D. Bonatto et al., “Molecular characterization of propolis-induced cell death in Saccharomyces cerevisiae,” Eukaryotic Cell, vol. 10, no. 3, pp. 398–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. F. Reis, J. C. T. Carvalho, L. K. G. Caputo et al., “Atividade antiinflamatória, antiúlcera gástrica e toxicidade subcrônica do extrato etanólico de própolis,” Revista Brasileira de Farmacognosia, vol. 9-10, no. 1, pp. 43–52, 2000. View at Publisher · View at Google Scholar
  12. P. Broz and D. M. Monack, “Molecular mechanisms of inflammasome activation during microbial infections,” Immunological Reviews, vol. 243, no. 1, pp. 174–190, 2011. View at Publisher · View at Google Scholar
  13. A. Dunne, “Inflammasome activation: from inflammatory disease to infection,” Biochemical Society Transactions, vol. 39, no. 2, pp. 669–673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez, “The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis,” Nature Immunology, vol. 10, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lamkanfi, T. D. Kanneganti, L. Franchi, and G. Núñez, “Caspase-1 inflammasomes in infection and inflammation,” Journal of Leukocyte Biology, vol. 82, no. 2, pp. 220–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Martinon and J. Tschopp, “Inflammatory caspases and inflammasomes: master switches of inflammation,” Cell Death and Differentiation, vol. 14, no. 1, pp. 10–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Miao, I. A. Leaf, P. M. Treuting et al., “Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria,” Nature Immunology, vol. 11, no. 12, pp. 1136–1142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Fink and B. T. Cookson, “Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages,” Cellular Microbiology, vol. 8, no. 11, pp. 1812–1825, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. N. Silveira and D. S. Zamboni, “Pore formation triggered by Legionella spp. is an Nlrc4 inflammasome-dependent host cell response that precedes pyroptosis,” Infection and Immunity, vol. 78, no. 3, pp. 1403–1413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Lamkanfi and V. M. Dixit, “Inflammasomes: guardians of cytosolic sanctity,” Immunological Reviews, vol. 227, no. 1, pp. 95–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. L. Newman, M. P. Printz, S. Liu et al., “Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1,” PLoS Pathogens, vol. 6, no. 5, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Franchi, A. Amer, M. Body-Malapel et al., “Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages,” Nature Immunology, vol. 7, no. 6, pp. 576–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ren, D. S. Zamboni, C. R. Roy, W. F. Dietrich, and R. E. Vance, “Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity,” PLoS Pathogens, vol. 2, no. 3, article e18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. L. Lightfield, J. Persson, N. J. Trinidad et al., “Differential requirements for NAIP5 in activation of the NLRC4 inflammasome,” Infection and Immunity, vol. 79, no. 4, pp. 1606–1614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. S. Sutterwala, Y. Ogura, D. S. Zamboni, C. R. Roy, and R. A. Flavell, “NALP3: a key player in caspase-1 activation,” Journal of Endotoxin Research, vol. 12, no. 4, pp. 251–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp, “Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1583–1589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Wu, T. Fernandes-Alnemri, and E. S. Alnemri, “Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes,” Journal of Clinical Immunology, vol. 30, no. 5, pp. 693–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Bauer, P. Duewell, C. Mayer et al., “Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome,” Gut, vol. 59, no. 9, pp. 1192–1199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Duewell, H. Kono, K. J. Rayner et al., “NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals,” Nature, vol. 464, no. 7293, pp. 1357–1361, 2010. View at Publisher · View at Google Scholar
  31. M. H. Zaki, K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T. D. Kanneganti, “The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis,” Immunity, vol. 32, no. 3, pp. 379–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. P. B. de Sousa, P. C. P. Bueno, L. E. Gregório et al., “A reliable quantitative method for the analysis of phenolic compounds in Brazilian propolis by reverse phase high performance liquid chromatography,” Journal of Separation Science, vol. 30, no. 16, pp. 2656–2665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. K. H. Berger and R. R. Isberg, “Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila,” Molecular Microbiology, vol. 7, no. 1, pp. 7–19, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. F. M. Marim, T. N. Silveira, D. S. Lima Jr., and D. S. Zamboni, “A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells,” PloS ONE, vol. 5, no. 12, Article ID e15263, 2010. View at Google Scholar · View at Scopus
  35. A. P. Bazo, M. A. M. Rodrigues, J. M. Sforcin, J. L. V. de Camargo, L. R. Ribeiro, and D. M. F. Salvadori, “Protective action of propolis on the rat colon carcinogenesis,” Teratogenesis Carcinogenesis and Mutagenesis, vol. 22, no. 3, pp. 183–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Chirumbolo, “Propolis as anti-inflammatory and anti-allergic compounds: which role for flavonoids?” International Immunopharmacology, vol. 11, no. 9, pp. 1386–1387, 2011. View at Publisher · View at Google Scholar
  37. G. Sartori, A. P. Pesarico, S. Pinton et al., “Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms,” Cell Biochemistry and Function, vol. 30, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar
  38. E. Contassot, H. D. Beer, and L. E. French, “Interleukin-1, inflammasomes, autoinflammation and the skin,” Swiss Medical Weekly, vol. 142, Article ID w13590, 2012. View at Publisher · View at Google Scholar
  39. M. Banerjee and M. Saxena, “Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes,” Clinica Chimica Acta, vol. 413, no. 15-16, pp. 1163–1170, 2012. View at Publisher · View at Google Scholar
  40. O. Gross, C. J. Thomas, G. Guarda, and J. Tschopp, “The inflammasome: an integrated view,” Immunological Reviews, vol. 243, no. 1, pp. 136–151, 2011. View at Publisher · View at Google Scholar
  41. H. W. Stout-Delgado, S. E. Vaughan, A. C. Shirali, R. J. Jaramillo, and K. S. Harrod, “Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin,” Journal of Immunology, vol. 188, no. 6, pp. 2815–2824, 2012. View at Publisher · View at Google Scholar
  42. S. Mariathasan, D. S. Weiss, K. Newton et al., “Cryopyrin activates the inflammasome in response to toxins and ATP,” Nature, vol. 440, no. 7081, pp. 228–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. J. McGahon, S. J. Martin, R. P. Bissonnette et al., “Chapter 9 the end of the (cell) line: methods for the study of apoptosis in vitro,” Methods in Cell Biology, vol. 46, pp. 153–185, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. D. M. Zuckman, J. B. Hung, and C. R. Roy, “Pore-forming activity is not sufficient for Legionella pneumophila phagosome trafficking and intracellular growth,” Molecular Microbiology, vol. 32, no. 5, pp. 990–1001, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Smolewski, E. Bedner, L. Du et al., “Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry,” Cytometry, vol. 44, no. 1, pp. 73–82, 2001. View at Publisher · View at Google Scholar
  46. D. S. Zamboni, K. S. Kobayashi, T. Kohlsdorf et al., “The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection,” Nature Immunology, vol. 7, no. 3, pp. 318–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Qu, S. Misaghi, K. Newton et al., “Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation,” Journal of Immunology, vol. 186, no. 11, pp. 6553–6561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Allam, M. N. Darisipudi, K. V. Rupanagudi, J. Lichtnekert, J. Tschopp, and H. J. Anders, “Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome,” Journal of Immunology, vol. 186, no. 5, pp. 2714–2718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. E. A. Miao, D. P. Mao, N. Yudkovsky et al., “Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3076–3080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Franchi, J. Stoolman, T. D. Kanneganti, A. Verma, R. Ramphal, and G. Núñez, “Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation,” European Journal of Immunology, vol. 37, no. 11, pp. 3030–3039, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Franchi, C. McDonald, T. D. Kanneganti, A. Amer, and G. Núñez, “Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense,” Journal of Immunology, vol. 177, no. 6, pp. 3507–3513, 2006. View at Google Scholar · View at Scopus
  52. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Bankova, “Chemical diversity of propolis and the problem of standardization,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Salatino, E. W. Teixeira, G. Negri, and D. Message, “Origin and chemical variation of Brazilian propolis,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 33–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Ansorge, D. Reinhold, and U. Lendeckel, “Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-β1 production of human immune cells,” Zeitschrift fur Naturforschung C, vol. 58, no. 7-8, pp. 580–589, 2003. View at Google Scholar · View at Scopus
  56. A. A. Korish and M. M. Arafa, “Propolis derivatives inhibit the systemic inflammatory response and protect hepatic and neuronal cells in acute septic shock,” Brazilian Journal of Infectious Diseases, vol. 15, no. 4, pp. 332–338, 2011. View at Google Scholar
  57. J. J. Song, J. G. Cho, S. J. Hwang, C. G. Cho, S. W. Park, and S. W. Chae, “Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells,” Acta Oto-Laryngologica, vol. 128, no. 12, pp. 1303–1307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. C. A. Dinarello, “Interleukin-1β and the autoinflammatory diseases,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2467–2470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. J. A. Duncan, X. Gao, M. T. H. Huang et al., “Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome,” Journal of Immunology, vol. 182, no. 10, pp. 6460–6469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. X. He, S. Mekasha, N. Mavrogiorgos, K. A. Fitzgerald, E. Lien, and R. R. Ingalls, “Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome,” Journal of Immunology, vol. 184, no. 10, pp. 5743–5754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Kayagaki, S. Warming, M. Lamkanfi et al. et al., “Non-canonical inflammasome activation targets caspase-11,” Nature, vol. 479, no. 7371, pp. 117–121, 2011. View at Publisher · View at Google Scholar
  62. C. Toma, N. Higa, Y. Koizumi et al., “Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-κB signaling,” Journal of Immunology, vol. 184, no. 9, pp. 5287–5297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. O. Gross, H. Poeck, M. Bscheider et al., “Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence,” Nature, vol. 459, no. 7245, pp. 433–436, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. A. G. Hise, J. Tomalka, S. Ganesan et al., “An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans,” Cell Host and Microbe, vol. 5, no. 5, pp. 487–497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Joly, N. Ma, J. J. Sadler, D. R. Soll, S. L. Cassel, and F. S. Sutterwala, “Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome,” Journal of Immunology, vol. 183, no. 6, pp. 3578–3581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. I. C. Allen, M. A. Scull, C. B. Moore et al., “The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA,” Immunity, vol. 30, no. 4, pp. 556–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Ichinohe, I. K. Pang, and A. Iwasaki, “Influenza virus activates inflammasomes via its intracellular M2 ion channel,” Nature Immunology, vol. 11, no. 5, pp. 404–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. V. Rajan, D. Rodriguez, E. A. Miao, and A. Aderem, “The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection,” Journal of Virology, vol. 85, no. 9, pp. 4167–4172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Ritter, O. Gross, S. Kays et al., “Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 47, pp. 20459–20464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Halle, V. Hornung, G. C. Petzold et al., “The NALP3 inflammasome is involved in the innate immune response to amyloid-β,” Nature Immunology, vol. 9, no. 8, pp. 857–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-associated uric acid crystals activate the NALP3 inflammasome,” Nature, vol. 440, no. 7081, pp. 237–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Shinkai, T. H. McCalmont, and K. S. Leslie, “Cryopyrin-associated periodic syndromes and autoinflammation,” Clinical and Experimental Dermatology, vol. 33, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus